1 tracked superinvestor hold Belite Bio Inc Sponsored (BLTE), worth $17M combined, led by Stanley Druckenmiller. Smart money is accumulating BLTE as of the latest 13F filings.
Current price
$153.24
+140.7%
1Y
Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery of vitamin A to the eye to reduce the accumulation of…
Market cap
$6.2B
P/E
-66.75
Div yield
0.0%
Revenue YoY
0.0%
Analyst target
$208
Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.
Superinvestors holding
1
tracked 13F / N-PORT funds
Combined value
$17M
disclosed long exposure
Tier-1 conviction
1
concentrated holders
Net this quarter
+1
1 buying · 0 selling
Smart money is net accumulating BLTE: 1 funds added or opened versus 0 trimming. 1 opened a brand-new position.
Belite Bio Inc Sponsored (BLTE) is held by 1 tracked funds worth $17M combined, 1 of them concentrated Tier-1 managers whose positions carry real conviction.
The largest position belongs to Stanley Druckenmiller at 0.5% of their book — no single tracked manager treats it as an outsized, top-weighted bet.
This quarter 1 fund opened a brand-new position (Stanley Druckenmiller), with 0 adding and 0 trimming — a net accumulation signal.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| New buy | 0.5% | $17M |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
Which superinvestors own BLTE?
1 tracked funds hold Belite Bio Inc Sponsored (BLTE), the largest being Stanley Druckenmiller (Duquesne Family Office) at 0.5% of its 13F portfolio. 1 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling BLTE?
In the most recent 13F quarter, 1 tracked fund added or opened BLTE and 0 trimmed it, including 1 brand-new position.
How much BLTE do tracked funds hold?
Combined disclosed long exposure to BLTE across tracked superinvestors is $17M as of the Mar 2026 filings.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Mar 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.